A detailed history of Dixon Mitchell Investment Counsel Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Dixon Mitchell Investment Counsel Inc. holds 86,764 shares of ZTS stock, worth $15.8 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
86,764
Previous 81,697 6.2%
Holding current value
$15.8 Million
Previous $14.3 Billion 18.46%
% of portfolio
0.77%
Previous 0.72%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$172.58 - $196.48 $874,462 - $995,564
5,067 Added 6.2%
86,764 $17 Billion
Q2 2024

Jul 11, 2024

BUY
$145.54 - $178.83 $11.9 Million - $14.6 Million
81,645 Added 157009.62%
81,697 $14.3 Billion
Q1 2024

Apr 18, 2024

BUY
$165.67 - $199.94 $8,614 - $10,396
52 New
52 $8.8 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $85.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Dixon Mitchell Investment Counsel Inc. Portfolio

Follow Dixon Mitchell Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Mitchell Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dixon Mitchell Investment Counsel Inc. with notifications on news.